To confirm whether high levels of full-length suPAR accelerate atherosclerosis, we used a murine Pcsk9-AAV model of induced atherosclerosis, which allows for the study of immunometabolic processes without the confounding effects of germline alterations seen with the apoE knockout and LDL receptor knockout models (53). The gene discussed is PCSK9; the disease is atherosclerosis.